A comparison between dexlansoprazole modified release-based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial.
Infect Drug Resist
; 12: 2923-2931, 2019.
Article
in En
| MEDLINE
| ID: mdl-31571945
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Prognostic_studies
Language:
En
Journal:
Infect Drug Resist
Year:
2019
Document type:
Article
Affiliation country:
Taiwan
Country of publication:
New Zealand